0001824293-22-000061.txt : 20220706
0001824293-22-000061.hdr.sgml : 20220706
20220706140357
ACCESSION NUMBER: 0001824293-22-000061
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220701
FILED AS OF DATE: 20220706
DATE AS OF CHANGE: 20220706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thorell Marella
CENTRAL INDEX KEY: 0001826323
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40034
FILM NUMBER: 221068243
MAIL ADDRESS:
STREET 1: 1226 CHARTER LANE
CITY: AMBLER
STATE: PA
ZIP: 19002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vallon Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001824293
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824369909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TWO LOGAN SQUARE
STREET 2: 100 N. 18TH STREET, SUITE 300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: (267) 207-3606
MAIL ADDRESS:
STREET 1: TWO LOGAN SQUARE
STREET 2: 100 N. 18TH STREET, SUITE 300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
4
1
wf-form4_165713062186980.xml
FORM 4
X0306
4
2022-07-01
0
0001824293
Vallon Pharmaceuticals, Inc.
VLON
0001826323
Thorell Marella
C/O VALLON PHARMACEUTICALS, INC.
100 N 18TH STREET, SUITE 300
PHILADELPHIA
PA
19103
1
0
0
0
Common Stock
2022-07-01
4
A
0
38023
0
A
38023
D
Represents the grant of restricted stock units (RSUs). The RSUs vest in four (4) equal quarterly installments such that the RSU will be fully vested on the first (1st) anniversary of the date of grant, subject to continued service with the Issuer. Each RSU represents the right to receive one share of common stock of Vallon Pharmaceuticals, Inc.
/s/ David Baker, attorney-in-fact
2022-07-06